HLS Therapeutics Inc. (HLTRF)

[~ Blue ~]

TSE:AM, public float under 7 million. insiders holds 61% of shares. i got message from the company.. here it is

Approximately 2/3 of the outstanding shares are owned by insiders - these include Michael Blair, Scotia Merchant Capital, Franklin Templeton and officers/directors (the first three make up approximately 60%). Therefore the public float is approximately 1/3 of the outstanding shares or just under 7 million shares.



Chris Nutt

Vice President.